Understand the source comparison
AHK-Cu Mechanism of Action Detailed: Receptor Pathway and Cellular Uptake Comparison
Understanding how AHK-Cu enters cells and activates receptors requires comparing it to other copper delivery systems and longer copper peptides. AHK-Cu (tripeptide) Peptide transporters (PEPT1/2) or direct CTR1 transfer 30–60 minutes at 10 µM 1–5 µM for measur
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Understanding how AHK-Cu enters cells and activates receptors requires comparing it to other copper delivery systems and longer copper peptides.
- AHK-Cu (tripeptide)
- Peptide transporters (PEPT1/2) or direct CTR1 transfer
- 30–60 minutes at 10 µM
- 1–5 µM for measurable LOX activity
- Integrin binding (α2β1) triggers focal adhesion kinase (FAK) signaling
- Fastest cellular uptake with lowest threshold—optimal for acute response studies
- GHK-Cu (tripeptide)
- Peptide transporters, slightly slower due to glycine steric effects
- 45–90 minutes at 10 µM
- 2–8 µM for measurable activity
- Similar integrin pathways plus TGF-β receptor modulation
- Broader signaling profile but higher threshold—better for sustained matrix remodeling
- Free Cu(II) ions
- CTR1 transporter (slow) or nonspecific albumin binding
- 2–4 hours, inconsistent
- 15–25 µM due to precipitation and albumin sequestration
- No direct receptor activation—effects purely through enzymatic cofactor insertion
- Poor bioavailability—most copper precipitates or binds albumin before cellular uptake
- Copper-histidine complex
- CTR1 transporter
- 60–120 minutes
- 8–15 µM
- None identified
- Intermediate bioavailability but lacks peptide signaling advantages
- Topical copper sulfate
- Passive diffusion (minimal)
- Negligible intracellular accumulation
- Not achieved at typical topical concentrations
- None
- Ineffective for intracellular enzyme activation—copper remains extracellular
- The comparison reveals why tripeptide copper chelates like AHK-Cu consistently outperform free copper salts in cell culture and tissue models: the peptide structure enables active transport mechanisms that free ions cannot access. Peptide transporters PEPT1 (SLC15A1) and PEPT2 (SLC15A2) recognize di- and tripeptides through their terminal amino and carboxyl groups, transporting them across cell membranes via proton-coupled symport. Once inside the cell, peptidases cleave the peptide bonds, releasing free amino acids and the copper ion in close proximity to intracellular copper chaperones (ATOX1, CCS) that deliver it to target enzymes.
- The integrin receptor pathway adds a second dimension to the AHK-Cu mechanism of action detailed. Integrins are heterodimeric transmembrane receptors that bind extracellular matrix proteins and trigger intracellular signaling cascades through focal adhesion complexes. The α2β1 integrin specifically recognizes collagen and certain peptide sequences containing basic residues—AHK-Cu's lysine at position three fits this profile. Binding activates focal adhesion kinase (FAK), which phosphorylates downstream targets including ERK1/2 (extracellular signal-regulated kinases) and PI3K/Akt pathways, both of which promote cell survival, proliferation, and matrix synthesis. This receptor-mediated signaling occurs independently of copper delivery, meaning AHK-Cu exerts dual effects: enzymatic through copper cofactor delivery, and signaling through integrin activation.